<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic analysis from the bone marrow of a patient with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> revealed the balanced translocation t(3;5)(q21;q31) </plain></SENT>
<SENT sid="1" pm="."><plain>Although this translocation has recently been described in six cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, this is the first such observation in a <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">preleukaemic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Subsequent evolution into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>(M2) was noted without the acquisition of additional cytogenetic changes and complete remission achieved with conventional cytotoxic chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>The relationships with other acquired abnormalities of chromosomes 3 and 5 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> are discussed </plain></SENT>
</text></document>